Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2010

01.06.2010 | Reproductive Medicine

The long-term effects of progesterone-only contraceptives on endometrium and ovary in rats

verfasst von: Nese Lortlar, Sevtap Kilic, Tuncay Peker, Ebru Zulfikaroglu, Suna Omeroglu, Deniz Erbas, H. Hamdi Celik, Ayhan Kormaz, Ilkan Tatar

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Progestin-only (p-only) contraceptives often cause breakthrough bleeding for unknown reasons. In this study, we aimed to evaluate the long-term effects of p-only contraceptives to gain a better understanding of breakthrough bleeding mechanism. Wistar rats were divided into etonorgesterel implant (Group 1, n = 25), depot medroxyprogesterone acetate injectable (Group 2, n = 25), and control groups (n = 5). Five rats each from groups 1 and 2 were examined every 10 days for up to 50 days after the medication. Uteri and ovaries were removed and prepared for immunohistochemisty and scanning electron microscopy. The tissue nitric oxide (NO) levels were determined by Griess reaction. Dynamic changes of endometrial estrogen and progesterone receptor immunoreactivity were observed in a time-dependent manner in groups 1 and 2. The number of endometrial pinopodes, which are small endometrial protrusions, increased in both groups. There was no difference between groups for the estrogen receptor in the surface epithelium of the ovary. Estrogen-alpha and progesterone receptor in follicular cells decreased in a time-dependent manner. The granulosa cells underwent atrophic and were disorganized. Decreased levels of uterine tissue NO were determined in groups 1 and 2. The effect of some p-only contraceptives make some dynamic changes in the endometrium, ovaries, steroid hormone receptors, cell morphology, and biochemical features of the tissues during their use.
Literatur
1.
Zurück zum Zitat Gallo MF, Grimes DA, Schulz KF, d’Arcangues C, Lopez LM (2005) Combination injectable contraceptives for contraception. Cochrane Database Syst Rev 20:CD004568 Gallo MF, Grimes DA, Schulz KF, d’Arcangues C, Lopez LM (2005) Combination injectable contraceptives for contraception. Cochrane Database Syst Rev 20:CD004568
2.
Zurück zum Zitat Sereepapong W, Chotnopparatpattara P, Taneepanichskul S, Markham R, Russell P, Fraser IS (2004) Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users. Hum Reprod 19:547–552CrossRefPubMed Sereepapong W, Chotnopparatpattara P, Taneepanichskul S, Markham R, Russell P, Fraser IS (2004) Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users. Hum Reprod 19:547–552CrossRefPubMed
3.
Zurück zum Zitat Hickey M, Fraser IS (2000) A functional model for progestogen-induced breakthrough bleeding. Hum Reprod 15:1–6CrossRefPubMed Hickey M, Fraser IS (2000) A functional model for progestogen-induced breakthrough bleeding. Hum Reprod 15:1–6CrossRefPubMed
4.
Zurück zum Zitat Oborná I, Novotný R, Brezinová J, Petrová P, Lichnovský V, Fingerová H (2004) Changes in the development of uterine pinopodes in steroid hormone supplemented cycles. Physiol Res 53:423–429PubMed Oborná I, Novotný R, Brezinová J, Petrová P, Lichnovský V, Fingerová H (2004) Changes in the development of uterine pinopodes in steroid hormone supplemented cycles. Physiol Res 53:423–429PubMed
5.
Zurück zum Zitat Taguchi M, Alfer J, Chwalisz K, Beier HM, Classen-Linke I (2000) Endothelial nitric oxide synthase is differently expressed in human endometrial vessels during the menstrual cycle. Mol Hum Reprod 6:185–190CrossRefPubMed Taguchi M, Alfer J, Chwalisz K, Beier HM, Classen-Linke I (2000) Endothelial nitric oxide synthase is differently expressed in human endometrial vessels during the menstrual cycle. Mol Hum Reprod 6:185–190CrossRefPubMed
7.
Zurück zum Zitat Khorram O, Garthwaite M, Magness RR (1999) Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women. J Clin Endocrinol Metab 84:2226–2232CrossRefPubMed Khorram O, Garthwaite M, Magness RR (1999) Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women. J Clin Endocrinol Metab 84:2226–2232CrossRefPubMed
8.
Zurück zum Zitat Bennink HJ (2000) The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 5:12–20PubMed Bennink HJ (2000) The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 5:12–20PubMed
9.
Zurück zum Zitat Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H (1998) Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril 69:714–721CrossRefPubMed Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H (1998) Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril 69:714–721CrossRefPubMed
10.
Zurück zum Zitat Hidalgo MM, Lisondo C, Juliato CT, Espejo-Arce X, Monteiro I, Bahamondes L (2006) Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants. Contraception 73:532–536CrossRefPubMed Hidalgo MM, Lisondo C, Juliato CT, Espejo-Arce X, Monteiro I, Bahamondes L (2006) Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants. Contraception 73:532–536CrossRefPubMed
11.
Zurück zum Zitat Miranda KM, Espey MG, Wink DA (2001) Nitric oxide. Biol and Chem 5:62–71 Miranda KM, Espey MG, Wink DA (2001) Nitric oxide. Biol and Chem 5:62–71
12.
Zurück zum Zitat Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126:131–138CrossRefPubMed Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126:131–138CrossRefPubMed
13.
Zurück zum Zitat Morison NB, Zhang J, Kaitu’u-Lino TJ, Fraser IS, Salamonsen LA (2007) The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women. Reproduction 133:309–321CrossRefPubMed Morison NB, Zhang J, Kaitu’u-Lino TJ, Fraser IS, Salamonsen LA (2007) The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women. Reproduction 133:309–321CrossRefPubMed
14.
Zurück zum Zitat Critchley HO, Bailey DA, Au CL, Affandi B (1993) Rogers. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum Reprod 8:1632–1639PubMed Critchley HO, Bailey DA, Au CL, Affandi B (1993) Rogers. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum Reprod 8:1632–1639PubMed
15.
Zurück zum Zitat Macpherson AM, Archer DF, Leslie S, Charnock-Jones DS, Makkink WK, Smith SK (1999) The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium. Hum Reprod 14:3080–3087CrossRefPubMed Macpherson AM, Archer DF, Leslie S, Charnock-Jones DS, Makkink WK, Smith SK (1999) The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium. Hum Reprod 14:3080–3087CrossRefPubMed
16.
Zurück zum Zitat Zhu P, Liu X, Luo H, Gu Z, Cheng J, Xu R, Lian S, Wu S, Wang J (1999) The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use. Hum Reprod 14(4):970–975CrossRefPubMed Zhu P, Liu X, Luo H, Gu Z, Cheng J, Xu R, Lian S, Wu S, Wang J (1999) The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use. Hum Reprod 14(4):970–975CrossRefPubMed
17.
Zurück zum Zitat Charnock-Jones DS, Macpherson AM, Archer DF, Leslie S, Makkink WK, Sharkey AM, Smith SK (2000) The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 3:85–95 Charnock-Jones DS, Macpherson AM, Archer DF, Leslie S, Makkink WK, Sharkey AM, Smith SK (2000) The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 3:85–95
18.
Zurück zum Zitat Creus M, Ordi J, Fábregues F, Casamitjana R, Carmona F, Cardesa A, Vanrell JA, Balasch J (2003) The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study. Hum Reprod 18:683–693CrossRefPubMed Creus M, Ordi J, Fábregues F, Casamitjana R, Carmona F, Cardesa A, Vanrell JA, Balasch J (2003) The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study. Hum Reprod 18:683–693CrossRefPubMed
19.
Zurück zum Zitat Stavreus-Evers A, Nikas G, Sahlin L, Eriksson H, Landgren BM (2001) Formation of pinopodes in human endometrium is associated with the concentrations of progesterone and progesterone receptors. Fertil Steril 76:782–791CrossRefPubMed Stavreus-Evers A, Nikas G, Sahlin L, Eriksson H, Landgren BM (2001) Formation of pinopodes in human endometrium is associated with the concentrations of progesterone and progesterone receptors. Fertil Steril 76:782–791CrossRefPubMed
20.
Zurück zum Zitat Alvarez-Sanchez F, Brache V, de Oca VM, Cochon L, Faúndes A (2000) Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant). Am J Obstet Gynecol 182:535–539CrossRefPubMed Alvarez-Sanchez F, Brache V, de Oca VM, Cochon L, Faúndes A (2000) Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant). Am J Obstet Gynecol 182:535–539CrossRefPubMed
21.
Zurück zum Zitat Bahamondes L, Hidalgo M, Petta CA, Diaz J, Espejo-Arce X, Monteiro-Dantas C (2003) Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant. J Reprod Med 48:637–640PubMed Bahamondes L, Hidalgo M, Petta CA, Diaz J, Espejo-Arce X, Monteiro-Dantas C (2003) Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant. J Reprod Med 48:637–640PubMed
22.
Zurück zum Zitat Bjersing L, Cajander S (1975) Ovulation and the role of the ovarian surface epithelium. Experientia 15:605–608CrossRef Bjersing L, Cajander S (1975) Ovulation and the role of the ovarian surface epithelium. Experientia 15:605–608CrossRef
23.
Zurück zum Zitat Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255–288CrossRefPubMed Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255–288CrossRefPubMed
24.
Zurück zum Zitat Katabuchi H, Okamura H (2003) Cell biology of human ovarian surface epithelial cells and ovarian carcinogenesis. Med Electron Microsc 36:74–86CrossRefPubMed Katabuchi H, Okamura H (2003) Cell biology of human ovarian surface epithelial cells and ovarian carcinogenesis. Med Electron Microsc 36:74–86CrossRefPubMed
25.
Zurück zum Zitat Brandenberger AN, Tee MK, Jaffe RB (1998) Estrogen receptor a (ER-a) and b (ER-b) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-depletion of ER-b in neoplastic tissues. J Clin Endocrinol Metab 83:1025–1028CrossRefPubMed Brandenberger AN, Tee MK, Jaffe RB (1998) Estrogen receptor a (ER-a) and b (ER-b) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-depletion of ER-b in neoplastic tissues. J Clin Endocrinol Metab 83:1025–1028CrossRefPubMed
26.
Zurück zum Zitat Lau KM, Mok SC, Ho SM (1999) Expression of human estrogen receptor-a and -b, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96:5722–5727CrossRefPubMed Lau KM, Mok SC, Ho SM (1999) Expression of human estrogen receptor-a and -b, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96:5722–5727CrossRefPubMed
27.
Zurück zum Zitat Vermeirsch H, Simoens P, Coryn M, Van den Broeck W (2001) Immunolocalization of progesterone receptors in the canine ovary and their relation to sex steroid hormone concentrations. Reproduction 122:73–83CrossRefPubMed Vermeirsch H, Simoens P, Coryn M, Van den Broeck W (2001) Immunolocalization of progesterone receptors in the canine ovary and their relation to sex steroid hormone concentrations. Reproduction 122:73–83CrossRefPubMed
28.
Zurück zum Zitat Ho SM (2003) Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 1:73CrossRefPubMed Ho SM (2003) Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 1:73CrossRefPubMed
29.
Zurück zum Zitat Cunat S, Hoffman P, Pujol P (2004) Estrogens and epithelial ovarian cancer. Gynecol Oncol 94:25–32CrossRefPubMed Cunat S, Hoffman P, Pujol P (2004) Estrogens and epithelial ovarian cancer. Gynecol Oncol 94:25–32CrossRefPubMed
30.
Zurück zum Zitat Rodgers RJ, Irving-Rodgers HF, van Wezel IL, Krupa M, Lavranos TC (2001) Dynamics of the membrana granulosa during expansion of the ovarian follicular antrum. Mol Cell Endocrinol 22(171):41–48CrossRef Rodgers RJ, Irving-Rodgers HF, van Wezel IL, Krupa M, Lavranos TC (2001) Dynamics of the membrana granulosa during expansion of the ovarian follicular antrum. Mol Cell Endocrinol 22(171):41–48CrossRef
31.
Zurück zum Zitat Hafez ES, Makabe S, Motta PM (1980) Surface ultrastructure of functional and nonfunctional human ovaries. Int J Fertil 25:94–99PubMed Hafez ES, Makabe S, Motta PM (1980) Surface ultrastructure of functional and nonfunctional human ovaries. Int J Fertil 25:94–99PubMed
32.
Zurück zum Zitat Chwalisz K, Garfield RE (2000) Role of nitric oxide in implantation and menstruation. Hum Reprod 15:96–111PubMed Chwalisz K, Garfield RE (2000) Role of nitric oxide in implantation and menstruation. Hum Reprod 15:96–111PubMed
33.
Zurück zum Zitat Zervou S, Klentzeris LD, Old RW (1999) Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia. Mol Hum Reprod 5:1048–1054CrossRefPubMed Zervou S, Klentzeris LD, Old RW (1999) Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia. Mol Hum Reprod 5:1048–1054CrossRefPubMed
34.
Zurück zum Zitat Telfer JF, Irvine GA, Kohnen G, Campbell S, Cameron IT (1997) Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualized human endometrium. Mol Hum Reprod 3:69–75CrossRefPubMed Telfer JF, Irvine GA, Kohnen G, Campbell S, Cameron IT (1997) Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualized human endometrium. Mol Hum Reprod 3:69–75CrossRefPubMed
35.
Zurück zum Zitat Bulbul A, Yağci A, Altunbaş K, Sevimli A, Celik HA, Karadeniz A, Akdağ E (2007) The role of nitric oxide in the effects of ovarian steroids on spontaneous myometrial contractility in rats. Theriogenology 68:1156–1168CrossRefPubMed Bulbul A, Yağci A, Altunbaş K, Sevimli A, Celik HA, Karadeniz A, Akdağ E (2007) The role of nitric oxide in the effects of ovarian steroids on spontaneous myometrial contractility in rats. Theriogenology 68:1156–1168CrossRefPubMed
36.
Zurück zum Zitat Shaamash AH, Zakhari MM (2005) Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding. Hum Reprod 20:302–306CrossRefPubMed Shaamash AH, Zakhari MM (2005) Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding. Hum Reprod 20:302–306CrossRefPubMed
Metadaten
Titel
The long-term effects of progesterone-only contraceptives on endometrium and ovary in rats
verfasst von
Nese Lortlar
Sevtap Kilic
Tuncay Peker
Ebru Zulfikaroglu
Suna Omeroglu
Deniz Erbas
H. Hamdi Celik
Ayhan Kormaz
Ilkan Tatar
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2010
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1356-x

Weitere Artikel der Ausgabe 6/2010

Archives of Gynecology and Obstetrics 6/2010 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.